Bausch Health Companies (TSE:BHC) Trading Down 2.3% – Here’s What Happened

Bausch Health Companies Inc. (TSE:BHC) traded down 2.3% on Thursday . The stock traded as low as C$10.02 and last traded at C$10.11. 523,547 shares were traded during trading, an increase of 16% from the average session volume of 451,074 shares. The stock had previously closed at C$10.35.

Analyst Ratings Changes

A number of equities analysts recently issued reports on BHC shares. Barclays raised Bausch Health Companies to a “hold” rating in a report on Monday, December 8th. Raymond James Financial upgraded shares of Bausch Health Companies to a “hold” rating in a research report on Monday, December 15th. Two analysts have rated the stock with a Hold rating, According to data from MarketBeat, Bausch Health Companies presently has a consensus rating of “Hold”.

Bausch Health Companies Trading Down 2.3%

The business has a 50-day moving average of C$9.57 and a 200-day moving average of C$9.38. The stock has a market capitalization of C$3.75 billion, a price-to-earnings ratio of 10.42, a PEG ratio of 0.21 and a beta of 0.54. The company has a debt-to-equity ratio of -1,831.94, a quick ratio of 0.58 and a current ratio of 1.19.

Bausch Health Companies (TSE:BHC) last announced its earnings results on Wednesday, October 29th. The company reported C$0.48 earnings per share (EPS) for the quarter. The business had revenue of C$2.68 billion for the quarter. Bausch Health Companies had a negative net margin of 1.88% and a positive return on equity of 15.87%. As a group, research analysts forecast that Bausch Health Companies Inc. will post 5.5472637 EPS for the current year.

About Bausch Health Companies

Bausch Health Companies Inc is a global company that develops manufactures and markets a range of pharmaceutical medical device and over-the-counter products primarily in the therapeutic areas of eye health gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. Our approximately 22000 employees are united around our mission of improving peoples lives with our health care products and we manufacture and market health care products directly or indirectly in approximately 100 countries.